Evidence map›Paper›PMID 24526113›Full record

ReviewCell cycle (Georgetown, Tex.)2014

Environmental signaling through the mechanistic target of rapamycin complex 1: mTORC1 goes nuclear.

Jason J Workman, Hongfeng Chen, R Nicholas Laribee

Open access · hybridAbstract readReview
In one paragraph

Review in Cell cycle (Georgetown, Tex.), 2014. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 16 papers.

0numbers the graph read from it
0cells of the map it votes in
16citing papers in PubMed
2.1field-weighted citation impact, top 13% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

16 citing papers in PubMed, 27 citations in OpenAlex.

  1. Review
  2. Article
  3. Article
  4. Article
  5. Review
  6. Article
  7. Article
  8. Review
  9. Article
  10. Review
  11. Article
  12. Yeast HMO1: Linker Histone Reinvented.Microbiology and molecular biology reviews : MMBR · 2017
    Review
  13. Article
  14. Article
  15. Review
  16. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

3 authors at 1 institution in 1 country.

Jason J WorkmanDepartment of Pathology and Laboratory Medicine and Center for Cancer Research; University of Tennessee Health Science Center; Memphis, TN USA.
Hongfeng ChenDepartment of Pathology and Laboratory Medicine and Center for Cancer Research; University of Tennessee Health Science Center; Memphis, TN USA.
R Nicholas LaribeeDepartment of Pathology and Laboratory Medicine and Center for Cancer Research; University of Tennessee Health Science Center; Memphis, TN USA.
West Cancer Center · US

Funding

Mechanisms of transcription coregulator usage by the target of rapamycin pathwayR01GM107040 · NIGMS · UNIVERSITY OF TENNESSEE HEALTH SCI CTR · PI LARIBEE, RONALD · 2013 to 2017
$1.4M
NIGMS NIH HHS 1R01GM107040-01NIGMS NIH HHS R01 GM107040
6 · The paper itself

Abstract

Mechanistic target of rapamycin complex 1 (mTORC1) is a well-known regulator of cell growth and proliferation in response to environmental stimuli and stressors. To date, the majority of mTORC1 studies have focused on its function as a cytoplasmic effector of translation regulation. However, recent studies have identified additional, nuclear-specific roles for mTORC1 signaling related to transcription of the ribosomal DNA (rDNA) and ribosomal protein (RP) genes, mitotic cell cycle control, and the regulation of epigenetic processes. As this area of study is still in its infancy, the purpose of this review to highlight these significant findings and discuss the relevance of nuclear mTORC1 signaling dysregulation as it pertains to health and disease.

Indexed as

AnimalsCell NucleusDNA, RibosomalEpigenesis, GeneticGene-Environment InteractionHumansMechanistic Target of Rapamycin Complex 1MitosisMultiprotein ComplexesRibosomesRNA Polymerase IISaccharomycetalesSignal TransductionTOR Serine-Threonine KinasesTranscription, GeneticDNA, RibosomalMechanistic Target of Rapamycin Complex 1Multiprotein ComplexesRNA Polymerase IITOR Serine-Threonine Kinasesacetylationcancerepigeneticshistonestarget of rapamycintranscription

Identifiers

PMID24526113
PMCPMC3979908
OpenAlexW1979718441

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.